Clinical significance of lupus anticoagulants in children

Journal of Pediatrics

Volumn 134, Issue 2, 1999, Pages 199-205

  Male, Christoph ^a,b   Lechner, Klaus ^a   Eichinger, Sabine ^a   Kyrle, Paul A ^a   Kapiotis, Stylianos ^a   Wank, Hans ^a   Kaider, Alexandra ^a   Pabinger, Ingrid ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTHROMBIN;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; BLEEDING TENDENCY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; MALE; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0033026455     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70416-6     Document Type: Article

References (38)

1. 1. Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994;84:2854-67.
2. 2. Triplett DA. Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78:1-31.
3. 3. Lechner K, Pabinger Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985;15:254-62.
4. 4. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112: 682-98.
5. 5. Vila P, Hernandez MC, Lopez Fernandez MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994;72: 209-13.
6. 6. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342:341-4.
7. 7. Asherson RA, Khamashta MA, Ordi Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366-74.
8. 8. Shergy WJ, Kredich DW, Pisetsky DS. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 1988;15:1389-94.
9. 9. Montes de Oca MA, Babron MC, Bletry O, Broyer M, Courtecuisse V, Fontaine JL, et al. Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 1991;66:713-7.
10. 10. Molta C. Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, et al. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives. Pediatrics 1993;92:849-53.
11. 11. Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994;148:398-402.
12. 12. Seaman DE, Londino AV Jr, Kwoh CK, Medsger TA Jr, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995;96:1040-5.
13. 13. Gattorno M, Buoncompagni A, Molinari AC, Barbano GC, Morreale G, Stalla F, et al. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol 1995;34:873-81.
14. 14. Toren A, Toren P, Many A, Mandel M, Mester R, Neumann Y, et al. Spectrum of clinical manifestations of antiphospholipid antibodies in childhood and adolescence. Pediatr Hematol Oncol 1993;10:311-5.
15. 15. Ravelli A, Martini A, Burgio GR. Antiphospholipid antibodies in paediatrics. Eur J Pediatr 1994;153:472-9.
16. 16. Manco Johnson MJ, Nuss R. Lupus anticoagulant in children with thrombosis. Am J Hematol 1995;48:240-3.
17. 17. von Scheven E, Athreya BH, Rose CD, Goldsmith DP, Morton L. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996;129:339-45.
18. 18. Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of anti-phospolipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994;94:500-3.
19. 19. Schöning M, Klein R, Krageloh Mann I, Falck M, Bien S, Berg PA, et al. Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood. Neuropediatrics 1994;25:8-14.
20. 20. Angelini L, Zibordi F, Zorzi G, Nardocci N, Caporali R, Ravelli A, et al. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. Neuropediatrics 1996;27:149-53.
21. 21. Brodeur GM, O'Neill PJ, Willimas JA. Acquired inhibitors of coagulation in nonhemophiliac children. J Pediatr 1980;96:439-41.
22. 22. Lee MT, Nardi MA, Hadzi Nesic J, Karpatkin M. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. Am J Hematol 1996;51:307-14.
23. 23. Eberhard A, Sparling C, Sudbury S, Ford P, Laxer R, Silverman E. Hypoprothrombinemia in childhood systemic lupus erythematosus. Semin Arthritis Rheum 1994;24:12-8.
24. 24. Mingers AM, Sutor AH. Lupus inhibitors in childhood. Haemostaseologie 1992;12:101-6.
25. 25. Becton DL, Stine KC. Transient lupus anticoagulant associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome. J Pediatr 1997;130:998-1000.
26. 26. Orris DJ, Lewis JH, Spero JA, Hasiba U. Blocking coagulation inhibitors in children taking penicillin. J Pediatr 1980;97:426-9.
27. 27. Singh AK, Rao KP, Kizer J, Lazarchick J. Lupus anticoagulants in children. Ann Clin Lab Sci 1988;18:384-7.
28. 28. Currimbhoy Z. Transitory anticoagulants in healthy children. Am J Pediatr Hematol Oncol 1984;6:210-2.
29. 29. Burk CD, Miller L, Handler SD, Cohen AR. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics 1992;89:691-5.
30. 30. Green D, Hougie C, Kazmier FJ, Lechner K, Mannucci PM, Rizza CR, et al. Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant. Thromb Haemost 1983;49:144-6.
31. 31. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-90.
32. 32. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983;61:684-92.
33. 33. Jäger U, Kapiotis S, Pabinger I, Puchhammer E, Kyrle PA, Lechner K. Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection. Ann Hematol 1993;67:95-9.
34. 34. Andrews PA, Frampton G, Cameron JS. Antiphospholipid syndrome and systemic lupus erythematosus [letter]. Lancet 1993;342:988-9.
35. 35. Finazzi G, Brancaccio V, Moia M, Ciaverella N, Mazzucconi MG, Schinco PC, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 1996;100:530-6.
36. 36. Ehrenstein MR, Swana M, Keeling D, Asherson R, Hughes GRV, Isenberg DA. Anti-DNA antibodies in the primary antiphospholipid antibody syndrome (PAPS). Br J Rheumatol 1993;32:362-5.
37. 37. Cassidy JT, Petty RE. Pediatric rheumatology. 3rd ed. Toronto: WB Saunders Co; 1995.
38. 38. Manco Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996;128:319-23.